Abstract
Islet transplantation has shown great promise as an experimental treatment for Type 1 diabetes, but current clinical protocols have problems with long-term graft survival when islets are transplanted into an inflammatory, immunogenic host environment. Encapsulation strategies designed to present a biocompatible barrier between graft and host may offer solutions to these problems.
| Original language | English |
|---|---|
| Pages (from-to) | 5-9 |
| Number of pages | 5 |
| Journal | The Biochemist |
| Volume | 38 |
| Issue number | 4 |
| Publication status | Published - Aug 2016 |
